Weld Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Weld Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,572	Closed	-$163K	–	711
2020 Q2	$163K	Sell	12,572 -12,610	-50%	-$151K	0.06%	407
2020 Q1	$233K	Sell	25,182 -8,892	-26%	-$124K	0.12%	281
2019 Q4	$566K	Buy	+34,074	New	+$552K	0.11%	312

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Weld Capital Management's OXFD Position: Q3 2020 in Review

Weld Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2020, closing a stake of 12,572 shares — an estimated $163K sold.

Weld Capital Management first reported a position in OXFD in Q4 2019 and held it in 3 quarters. The position peaked at $566K in Q4 2019. 71 funds tracked by Wall St. Rank hold OXFD as of Q3 2020.

Weld Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2020 after selling out during the quarter.
Weld Capital Management sold 12,572 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2020, an estimated $163K.
Weld Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2019 and held it in 3 quarters.
Weld Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $566K in Q4 2019.
71 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2020.

Based on Weld Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.